Viking Therapeutics (NASDAQ:VKTX) Releases Earnings Results

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.02, Briefing.com reports. Viking Therapeutics’s quarterly revenue was up .0% on a year-over-year basis. During the same period in the prior year, the business earned ($0.23) […]

Related Keywords

Raymond James ,Charlesa Rowland Jr ,Stifel Nicolaus ,Jpmorgan Chase Co ,Sassicaia Capital Advisers ,Cetera Advisor Networks ,Securities Exchange Commission ,Therapeutics Inc ,Viking Therapeutics ,Get Free Report ,Director Charles ,Exchange Commission ,Capital Advisers ,Bay Capital Management ,Advisor Networks ,Viking Therapeutics Daily ,Nasdaq Vktx ,Vktx ,Medical ,Earnings ,